Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard Barasa

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
RSC Advances|May 13, 2022
An efficient one-pot conversion of carboxylic acids into benzimidazoles <i>via</i> an HBTU-promoted methodologyLeonard Barasa, Sabesan Yoganathan
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 1, 2023
Protein citrullination: inhibition, identification and insertionLeonard Barasa, Paul R Thompson
Biochemistry|June 12, 2023
SARM1, an Enzyme Involved in Axon Degeneration, Catalyzes Multiple Activities through a Ternary Complex MechanismJanneke D Icso, Leonard Barasa, Paul R Thompson
ACS Chemical Biology|October 23, 2025
Development of a Chemoproteomic Platform to Identify Sites of (Homo)citrullination within Complex ProteomesSarah A Mann, Leonard Barasa, Paul R Thompson, et al.
Scientific Reports|July 15, 2022
Discovery of a novel class of benzimidazoles as highly effective agonists of bone morphogenetic protein (BMP) receptor signalingSheyda Najafi, Leonard Barasa, Sammy Y Huang, et al.
Scientific Reports|August 14, 2025
N,N-Diethylacetamide and N,N-Dipropylacetamide inhibit the NF-kB pathway in in vitro, ex vivo and in vivo models of inflammation-induced preterm birthSamir Gorasiya, Juliet Mushi, Sabesan Yoganathan, et al.
Frontiers in Bioscience (Landmark Edition)|November 2, 2023
Novel Indolyl-Benzimidazole Compounds Promote <i>in vitro</i> Wound Healing and Osteogenic Differentiation of Pluripotent CellsSheyda Najafi, Leonard Barasa, Jilian Maxine J Frianela, et al.
ACS Chemical Biology|June 30, 2026
Development of Next-Generation Fluoroacetamidine-Containing Activity-Based Probes for the Selective Labeling of the Protein Arginine Deiminases (PADs)Thomas Rossetti, Lin Han, Leonard Barasa, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 5, 2019
Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatmentNishant S Kulkarni, Vineela Parvathaneni, Snehal K Shukla, et al.
ACS Infectious Diseases|December 9, 2024
High-Throughput Screening of More Than 30,000 Compounds for Anthelmintics against Gastrointestinal Nematode ParasitesMostafa A Elfawal, Emily Goetz, Youmie Kim, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
RSC Advances|May 13, 2022
An efficient one-pot conversion of carboxylic acids into benzimidazoles <i>via</i> an HBTU-promoted methodologyLeonard Barasa, Sabesan Yoganathan
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 1, 2023
Protein citrullination: inhibition, identification and insertionLeonard Barasa, Paul R Thompson
Biochemistry|June 12, 2023
SARM1, an Enzyme Involved in Axon Degeneration, Catalyzes Multiple Activities through a Ternary Complex MechanismJanneke D Icso, Leonard Barasa, Paul R Thompson
ACS Chemical Biology|October 23, 2025
Development of a Chemoproteomic Platform to Identify Sites of (Homo)citrullination within Complex ProteomesSarah A Mann, Leonard Barasa, Paul R Thompson, et al.
Scientific Reports|July 15, 2022
Discovery of a novel class of benzimidazoles as highly effective agonists of bone morphogenetic protein (BMP) receptor signalingSheyda Najafi, Leonard Barasa, Sammy Y Huang, et al.
Scientific Reports|August 14, 2025
N,N-Diethylacetamide and N,N-Dipropylacetamide inhibit the NF-kB pathway in in vitro, ex vivo and in vivo models of inflammation-induced preterm birthSamir Gorasiya, Juliet Mushi, Sabesan Yoganathan, et al.
Frontiers in Bioscience (Landmark Edition)|November 2, 2023
Novel Indolyl-Benzimidazole Compounds Promote <i>in vitro</i> Wound Healing and Osteogenic Differentiation of Pluripotent CellsSheyda Najafi, Leonard Barasa, Jilian Maxine J Frianela, et al.
ACS Chemical Biology|June 30, 2026
Development of Next-Generation Fluoroacetamidine-Containing Activity-Based Probes for the Selective Labeling of the Protein Arginine Deiminases (PADs)Thomas Rossetti, Lin Han, Leonard Barasa, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 5, 2019
Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatmentNishant S Kulkarni, Vineela Parvathaneni, Snehal K Shukla, et al.
ACS Infectious Diseases|December 9, 2024
High-Throughput Screening of More Than 30,000 Compounds for Anthelmintics against Gastrointestinal Nematode ParasitesMostafa A Elfawal, Emily Goetz, Youmie Kim, et al.
Pageof 3